791 related articles for article (PubMed ID: 3489522)
1. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
Fernandez-Pol JA; Klos DJ; Grant GA
Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
[TBL] [Abstract][Full Text] [Related]
2. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
[TBL] [Abstract][Full Text] [Related]
3. Growth stimulation, altered regulation of epidermal growth factor receptors, and autocrine transformation of spontaneously transformed normal rat kidney cells by transforming growth factor beta.
Nugent MA; Lane EA; Keski-Oja J; Moses HL; Newman MJ
Cancer Res; 1989 Jul; 49(14):3884-90. PubMed ID: 2786745
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of transforming growth factor beta 1 on the growth of poorly and highly metastatic murine melanoma cells.
Mooradian DL; Purchio AF; Furcht LT
Cancer Res; 1990 Jan; 50(2):273-7. PubMed ID: 2295066
[TBL] [Abstract][Full Text] [Related]
5. Effect of epidermal growth factor/transforming growth factor alpha and transforming growth factor beta 1 on growth in vitro of rat urinary bladder carcinoma cells.
Kawamata H; Azuma M; Kameyama S; Nan L; Oyasu R
Cell Growth Differ; 1992 Nov; 3(11):819-25. PubMed ID: 1467309
[TBL] [Abstract][Full Text] [Related]
6. Effect of phorbol esters on the activity of purified transforming growth factors.
Kraft AS
Cancer Res; 1986 Apr; 46(4 Pt 1):1764-7. PubMed ID: 3004705
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factors produced by normal and neoplastically transformed rat liver epithelial cells in culture.
Liu C; Tsao MS; Grisham JW
Cancer Res; 1988 Feb; 48(4):850-5. PubMed ID: 3276400
[TBL] [Abstract][Full Text] [Related]
8. Presence of transforming growth factors in human breast cancer cells.
Salomon DS; Zwiebel JA; Bano M; Losonczy I; Fehnel P; Kidwell WR
Cancer Res; 1984 Sep; 44(9):4069-77. PubMed ID: 6331663
[TBL] [Abstract][Full Text] [Related]
9. Mouse Balb/c3T3 cell mutant with low epidermal growth factor receptor activity: induction of stable anchorage-independent growth by transforming growth factor beta.
Kuratomi Y; Ono M; Yasutake C; Mawatari M; Kuwano M
J Cell Physiol; 1987 Jan; 130(1):51-7. PubMed ID: 3468117
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic transformation of normal rat kidney cells in a growth-factor-defined medium: induction by a neuroblastoma-derived transforming growth factor independently of the EGF receptor.
van Zoelen EJ; van Oostwaard TM; van der Saag PT; de Laat SW
J Cell Physiol; 1985 May; 123(2):151-60. PubMed ID: 2984216
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
[TBL] [Abstract][Full Text] [Related]
12. Induction of anchorage-independent growth by epidermal growth factor and altered sensitivity to type beta transforming growth factor in partially transformed rat kidney cells.
Newman MJ; Lane EA; Nugent MA; Racker E
Cancer Res; 1986 Nov; 46(11):5842-50. PubMed ID: 3019539
[TBL] [Abstract][Full Text] [Related]
13. Characterization of transforming growth factors produced by the insulin-independent teratoma-derived cell line 1246-3A.
Yamada Y; Serrero G
J Cell Physiol; 1989 Aug; 140(2):254-63. PubMed ID: 2663884
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
[TBL] [Abstract][Full Text] [Related]
15. Differential growth sensitivity to 4-cis-hydroxy-L-proline of transformed rodent cell lines.
Ciardiello F; Sanfilippo B; Yanagihara K; Kim N; Tortora G; Bassin RH; Kidwell WR; Salomon DS
Cancer Res; 1988 May; 48(9):2483-91. PubMed ID: 2833347
[TBL] [Abstract][Full Text] [Related]
16. Orthovanadate both mimics and antagonizes the transforming growth factor beta action on normal rat kidney cells.
Rijksen G; Völler MC; Van Zoelen EJ
J Cell Physiol; 1993 Feb; 154(2):393-401. PubMed ID: 8425920
[TBL] [Abstract][Full Text] [Related]
17. Antagonistic actions of retinoic acid and dexamethasone on anchorage-independent growth and epidermal growth factor binding of normal rat kidney cells.
Roberts AB; Anzano MA; Lamb LC; Smith JM; Sporn MB
Cancer Res; 1984 Apr; 44(4):1635-41. PubMed ID: 6322983
[TBL] [Abstract][Full Text] [Related]
18. Multiplicity of transforming growth factors in human malignant effusions.
Seo MK; Lynch KE; Podolsky DK
Cancer Res; 1988 Apr; 48(7):1792-7. PubMed ID: 2894891
[TBL] [Abstract][Full Text] [Related]
19. Production of transforming growth factors by human colon cancer lines.
Coffey RJ; Shipley GD; Moses HL
Cancer Res; 1986 Mar; 46(3):1164-9. PubMed ID: 3002610
[TBL] [Abstract][Full Text] [Related]
20. Purification of melanoma growth stimulatory activity.
Richmond A; Thomas HG
J Cell Physiol; 1986 Dec; 129(3):375-84. PubMed ID: 3465735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
